HUNgarian COronaVirus Disease-19 Epidemiological Research

Overview

Hungarian CoronaVirus disease-19 Epidemiological Research

Full Title of Study: “Hungarian CoronaVirus Disease-19 Epidemiological Research”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: May 1, 2021

Detailed Description

The planned large-scale, cross-sectional, representative population screening can show the prevalence of COVID-19 and the degree of infection and trans-infection in Hungary after more than one month of strict restriction. In addition, it can have an impact on further actions, and we can track the impact of the decisions we make by repeating the screenings.

Clinical Trial Outcome Measures

Primary Measures

  • COVID-19 rate
    • Time Frame: 1 year
    • The rate of the infected patients, asymptomatic carrier and healed patients

Participating in This Clinical Trial

Inclusion Criteria

  • Hungarian male or female patients aged 14 and over who live in private households – Inactivated social security number does not infer the exclusion of the study Exclusion Criteria:

  • Patients under the age of 14 – Patients living in institutional households

Gender Eligibility: All

Minimum Age: 14 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Semmelweis University Heart and Vascular Center
  • Collaborator
    • Semmelweis University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Béla Merkely, PhD,DSc, Principal Investigator, Semmelweis University Heart and Vascular Center
  • Overall Contact(s)
    • Béla Merkely, PhD,DSc, +36 20 825 8000, rektor@semmelweis-univ.hu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.